EMS (pharmaceuticals)
EMS is the biggest domestic pharmaceutical company in Brazil,.[1] Founded in the mid-1950s, the company has six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia
 | |
| Type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1950 |
| Headquarters | Hortolândia, Brazil |
Key people | Waldir Eschberger, (CEO) |
| Products | Drugs and generic drug |
| Revenue |  US$ 1.3 billion (2016) |
Number of employees | 4,500 |
| Subsidiaries | Galenika a.d. Brace Pharma |
| Website | www.ems.com.br |
EMS operates through five divisions:
- EMS Similars - markets similares; a class of pharmaceuticals peculiar to the Brazilian market. Not generics but not original brands either;
- EMS Generics - markets generics;
- EMS Sigma Pharma - markets branded medicines;
- EMS Hospital - markets drugs to hospitals;
- EMS Consumer - markets OTC drugs.
Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies.
EMS's Brazilian main competitors are Hypermarcas, Eurofarma, Aché and Cristália.
References
- Focus Reports "Brazil: Big Dancer Takes the Floor" Archived 2011-07-11 at the Wayback Machine Pharmaceutical Executive, October 2007
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.